Britannia Life Sciences Inc. (CSE:BLAB)
Canada · Delayed Price · Currency is CAD 0.0700
0.00 (0.00%)
Oct 30, 2026, 10:45 AM EDT
Britannia Life Sciences Market Cap
Britannia Life Sciences has a market cap or net worth of CAD 11.52 million as of October 30, 2026. It is the 42,475th most valuable company in the world and the 1,515th biggest in Canada. Its market cap has decreased by 25.26% in one year.
Market Cap
11.52M
Enterprise Value
-681.26K
Revenue
406.44K
Global Rank
Country Rank
#1,515 Canada
PE Ratio
0.69
ChartMarket Cap Chart
Since November 18, 2021, Britannia Life Sciences's market cap has decreased from 41.95M to 11.52M, a decrease of -72.53%. That is a compound annual growth rate of -22.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 11.52M | -21.10% |
| Dec 31, 2025 | 14.60M | 12.50% |
| Dec 19, 2024 | 12.98M | 6.67% |
| Dec 29, 2023 | 12.17M | 7.14% |
| Dec 30, 2022 | 11.36M | -60.48% |
| Dec 31, 2021 | 28.74M | -31.48% |
| Nov 18, 2021 | 41.95M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharmala Biotech Holdings | 18.65M |
| Onco-Innovations | 15.92M |
| Lobe Sciences | 15.28M |
| Rapid Dose Therapeutics | 14.47M |
| Alzai Health | 12.96M |
| PreveCeutical Medical | 12.76M |
| Hemostemix | 12.69M |
| Marvel Biosciences | 8.86M |